Coagulation and transfusion in the postoperative bleeding patient

Current Opinion in Critical Care

Volumn 20, Issue 4, 2014, Pages 460-466

  Kozek Langenecker, Sibylle A ^a  

^a Evangelical Hospital Vienna   (Austria)

Author keywords

Fibrinogen concentrate; Plasma; Rotational thromboelastometry; Thrombelastography

Indexed keywords

APROTININ; CYTOCHALASIN D; DESMOPRESSIN; ECARIN; FIBRINOGEN; FIBRINOGEN CONCENTRATE; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT THROMBOPLASTIN; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID;

ANEMIA; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; BLOOD VOLUME; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; HUMAN; INTENSIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; REVIEW; ROTATIONAL THROMBOELASTOMETRY; SURVIVAL; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; BLOOD CLOTTING; BLOOD COAGULATION DISORDERS; BLOOD LOSS, SURGICAL;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HUMANS; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; THROMBELASTOGRAPHY;

EID: 84904060548     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000109     Document Type: Review

References (39)

1. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30:270-382
2. Spahn D, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: An updated European guideline. Crit Care 2013; 17:R76
3. Shander A, Hofmann A, Isbister J, Van Aken H. Patient blood management: The new frontier. Best Pract Res Clin Anaesthesiol 2013; 27:5-10
4. Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol 2007; 73:401-415. (Pubitemid 47249577
5. Hardy JF, de Moerloose P, Samama CM. Massive transfusion and coagulopathy: Pathophysiology and implications for clinical management. Can J Anaesth 2006; 53 (Suppl 2):S40-58 (Pubitemid 44150884)
6. Schreiber MA, Differding J, Thorborg P, et al. Hypercoagulability is most prevalent early after injury and in female patients. J Trauma ; 58D 2005:475-480
7. Kaufmann CR, Dwyer KM, Crews JD, et al. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997; 42:716-720
8. Armand R, Hess Jr. Treating coagulopathy in trauma patients. Transfus Med Rev 2003; 17:223-231. (Pubitemid 36900330
9. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005; 103:654-660. (Pubitemid 41243429
10. Meyer AS, Meyer MA, Sørensen AM, et al. Thrombelastography and rotational thromboelastometry early amplitudes in 182 trauma patients with clinical suspicion of severe injury. J Trauma Acute Care Surg 2014; 76:682-690
11. De Robertis E, Kozek-Langenecker S, Tufano R, et al. Coagulopathy induced by acidosis, hypothermia and hypocalcaemia in severe bleeding (review). Minerva Anestesiol 2014. [Epub ahead of print]
12. Quaknine-Orlando B, Samama CM, Riou B, et al. Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology 1999; 90:1454-1461. (Pubitemid 29205651
13. Gerlach R, Raabe A, Zimmermann M, et al. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol 2000; 54:260-264
14. Kozek-Langenecker S. Monitoring of hemostasis in emergency medicine. In: Vincent JL, editor. Yearbook of intensive care and emergency medicine. Berlin-Heidelberg: Springer-Verlag; 2007. p. 847-L860
15. Afshari A,Wikkelsø A, Brok J, et al. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011; 3:CD007871
16. Stensballe J, Ostrowski SR, Johansson PI. Viscoelastic guidance of resuscitation. Curr Opin Anaesthesiol 2014; 27:212-218
17. Wikkelsø A, Lunde J, Johansen M, et al. Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev 2013; 8:CD008864
18. Kozek-Langenecker SA. Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol 2010; 24:27-40
19. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27:81-90. (Pubitemid 40515992
20. www.perioperativebleeding.org [Accessed 2 March 2014].
21. Management of trauma-induced coagulopathy (TIC app); Apple app store, search term: OEGARI [Accessed 2 March 2014].
22. Sørensen B, Johansen P, Christiansen K, et al. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1:551-558
23. Calatzis A, Peetz D, Haas S, et al. Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and lowmolecular- weight heparins, fondaparinux, and thrombin inhibitors. Am J Clin Pathol 2008; 130:446-454
24. Scharbert G, Auer A, Kozek-Langenecker S. Evaluation of the Platelet Mapping Assay on rotational thromboelastometry ROTEM. Platelets 2009; 20:125-130
25. Erber WN, Perry DJ. Plasma and plasma products in the treatment of massive haemorrhage. Best Pract Res Clin Haematol 2006; 19:97-112. (Pubitemid 43118866
26. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81:360-365
27. Kozek-Langenecker S, Sørensen B, Hess H, Spahn D. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: A systematic review. Crit Care 2011; 15:R239
28. Sörensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010; 149:834-843
29. Ahmed S, Harrity C, Johnson S, et al. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage: An observational study. Transfus Med 2012; 22:344-349
30. Adelmann D, Klaus DA, Illievich U, et al. Fibrinogen but not factor XIII deficiency is associated with bleeding after craniotomy. Br J Anaesth 2014; pii: Aeu133. [Epub ahead of print]
31. Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: A prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117:531-547
32. Kozek-Langenecker S, Bettelheim P, Giurea A, et al. Interdisciplinary recommendations for the management of anaemia (patient blood management). 2013; http://www.oegari.at/web-files/dateiarchiv/473/PBM%20consensus %20of%20Austrian%20Societies%20&%20Organisations%202013%20 Version%201.1.pdf. [Accessed 2 March 2014]
33. World Health Organization (WHO) 63rd World Health Assembly. Availability, safety and quality of blood products (2010). Available at: Http://apps.who.int/ gb/ebwha/pdf-files/WHA63/A63-R12-en.pdf. [Accessed 2 March 2014]
34. Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50:753-765
35. Inaba K, Branco BC, Rhee P, et al. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010; 210:957-965
36. Watson GA, Sperry JL, Rosengart MR, et al. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009; 67:221-227
37. Khan H, Belsher J, Yilmaz M, et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007; 131:1308-1314. (Pubitemid 46762333
38. Chowdhury P, Saayman AG, Paulus U, et al. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125:69-73. (Pubitemid 38453280
39. Riskin DJ, Tsai TC, Riskin L, et al. Massive transfusion protocols: The role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009; 209:198-205.